The clinical impact of circulating caspase-3 p17 level: A potential new biomarker for myocardial injury and cardiovascular disease

Future Cardiology

Volumn 7, Issue 4, 2011, Pages 443-445

  Singh, Kanwar P ^a   Jaffe, Allan S ^b   Liang, Bruce T ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

apoptosis; heart failure; infarct; reperfusion

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CASPASE 3; CASPASE 3 P17; CREATINE KINASE; CREATINE KINASE MB; LACTATE DEHYDROGENASE; MYOGLOBIN; PROTEIN P17; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; APOPTOSIS; CARDIOVASCULAR DISEASE; CELL DEATH; ENZYME BLOOD LEVEL; HEART MUSCLE INJURY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

APOPTOSIS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CASPASE 3; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM;

EID: 79961076739     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.11.29     Document Type: Review

References (17)

1. Jaffe AS. Chasing troponin. How low can you go if you can see the rise? J. Am. Coll. Card. 48(9), 1763-1764 (2006).
2. Agosto M, Azrin M, Singh K, Jaffe AS, Liang BT. Serum caspase-3 p17 fragment is elevated in patients with ST-segment elevation myocardial infarction: a novel observation. J. Am. Coll. Card. 57(2), 220-221 (2011).
3. Thygesen K, Alper JS, White HD. Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction: universal definition of myocardial infarction. Circulation 116, 2634-2653 (2007).
4. Feng J, Schaus BJ, Fallavollita JA et al. Preload induces troponin I degradation independently of myocardial ischemia. Circulation 103, 2035-2037 (2001). (Pubitemid 32373003)
5. Hessel MHM, Atsma DE, van der Valk EJM, Bax WH, Schalij MJ, van der Laarse A. Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflugers Arch. Eur. J. Physiol. 455, 979-986 (2008). (Pubitemid 351169974)
6. Sabatine MS, Morrow DA, de Lemos JA et al. Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur. Heart J. 30, 162-169 (2009).
7. Olivetti G, Quaini F, Sala R et al. Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart. J. Mol. Cell Cardiol. 28, 2005-2016 (1996). (Pubitemid 26340560)
8. Kajstura J, Cheng W, Reiss K et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab. Invest. 74, 86-107 (1996). (Pubitemid 26041012)
9. Gottlieb RA, Burleson KO, Kloner RA et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Inv. 94, 1621-1628 (1994). (Pubitemid 24309885)
10. Saraste A, Pulkki K, Kallajoki M et al. Apoptosis in human acute myocardial infarction. Circulation 95, 320-323 (1997). (Pubitemid 27056193)
11. Abbate A, Bussani R, Biondi-Zoccai GGL et al. Infarct-related artery occlusion, tissue markers of ischemia, and increased apoptosis in the peri-infarct viable myocardium. Eur. Heart J. 26, 2039-2045 (2005). (Pubitemid 41435731)
12. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: Circulation 81, 1161-1172 (1990).
13. Anversa P, Olivetti G, Meggs LG et al. Cardiac anatomy and ventricular loading after myocardial infarction. Circulation 87(Suppl. 7), 22-27 (1993).
14. Page E, Polimeni PI. Ultrastructural changes in the ischemic zone bordering experimental infarcts in rat left ventricles. Am. J. Path. 87, 81-104 (1977). (Pubitemid 8068986)
15. Cheng W, Li B, Kajstura J et al. Stretch-induced programmed myocyte cell death. J. Clin. Invest. 96(5), 2247-2259 (1995).
16. Budihardjo I, Oliver H, Lutter M et al. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15, 269-290 (1999). (Pubitemid 32250377)
17. Sinning J-M, Losch J, Walenta K et al. Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur. Heart. J. DOI: 10.1093/eurheartj/ehq478 (2010) (Epub ahead of print).